Arcus Capital Partners LLC Takes $678,000 Position in Cencora, Inc. $COR

Arcus Capital Partners LLC purchased a new position in shares of Cencora, Inc. (NYSE:COR) during the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 2,158 shares of the company’s stock, valued at approximately $678,000.

Several other large investors also recently bought and sold shares of COR. Kemnay Advisory Services Inc. purchased a new position in shares of Cencora during the 4th quarter worth $25,000. Oakworth Capital Inc. acquired a new stake in shares of Cencora during the 4th quarter worth approximately $26,000. Elyxium Wealth LLC purchased a new stake in shares of Cencora during the 4th quarter valued at approximately $27,000. Archer Investment Corp raised its holdings in Cencora by 134.3% in the 4th quarter. Archer Investment Corp now owns 82 shares of the company’s stock valued at $28,000 after buying an additional 47 shares during the period. Finally, Motiv8 Investments LLC acquired a new position in Cencora in the fourth quarter valued at about $29,000. Hedge funds and other institutional investors own 97.52% of the company’s stock.

Analyst Ratings Changes

COR has been the subject of several research analyst reports. Morgan Stanley set a $342.00 target price on shares of Cencora in a research note on Friday, May 8th. Barclays cut their price target on shares of Cencora from $425.00 to $350.00 and set an “overweight” rating on the stock in a research note on Wednesday, June 10th. Weiss Ratings cut shares of Cencora from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Tuesday, June 30th. Robert W. Baird cut their target price on shares of Cencora from $420.00 to $339.00 and set an “outperform” rating on the stock in a research note on Thursday, May 7th. Finally, Evercore set a $360.00 target price on shares of Cencora in a report on Wednesday, April 8th. Eleven equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $367.75.

Insider Buying and Selling

In other Cencora news, Director Lauren M. Tyler bought 550 shares of the company’s stock in a transaction on Monday, June 22nd. The stock was purchased at an average cost of $270.23 per share, for a total transaction of $148,626.50. Following the acquisition, the director owned 4,359 shares of the company’s stock, valued at $1,177,932.57. The trade was a 14.44% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through the SEC website. Insiders own 0.38% of the company’s stock.

Cencora Stock Down 0.1%

Cencora stock opened at $307.72 on Friday. The stock’s 50 day moving average price is $279.98 and its 200 day moving average price is $317.68. Cencora, Inc. has a 1-year low of $244.82 and a 1-year high of $377.54. The company has a market cap of $59.87 billion, a PE ratio of 23.60, a price-to-earnings-growth ratio of 1.71 and a beta of 0.58. The company has a debt-to-equity ratio of 3.40, a current ratio of 0.95 and a quick ratio of 0.59.

Cencora (NYSE:COR) last released its earnings results on Wednesday, May 6th. The company reported $4.75 EPS for the quarter, missing analysts’ consensus estimates of $4.82 by ($0.07). Cencora had a net margin of 0.78% and a return on equity of 135.20%. The business had revenue of $78.36 billion during the quarter, compared to analyst estimates of $81.09 billion. During the same period last year, the business posted $4.42 EPS. Cencora’s revenue was up 3.9% compared to the same quarter last year. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. On average, sell-side analysts predict that Cencora, Inc. will post 17.79 EPS for the current fiscal year.

Cencora Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, June 1st. Investors of record on Friday, May 15th were paid a $0.60 dividend. This represents a $2.40 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date of this dividend was Friday, May 15th. Cencora’s dividend payout ratio is presently 18.40%.

Cencora announced that its Board of Directors has approved a share repurchase program on Thursday, May 21st that permits the company to buyback $2.00 billion in shares. This buyback authorization permits the company to purchase up to 3.9% of its stock through open market purchases. Stock buyback programs are typically an indication that the company’s board of directors believes its stock is undervalued.

About Cencora

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.